M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Total Equity Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Total Equity
$495.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Equity
-$148.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Equity
CHf123.4m
CAGR 3-Years
-13%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Equity
$1.9B
CAGR 3-Years
-8%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Total Equity
CHf155.6m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Total Equity
CHf268.2m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Total Equity?
Total Equity
495.7m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Total Equity amounts to 495.7m USD.

What is MoonLake Immunotherapeutics's Total Equity growth rate?
Total Equity CAGR 1Y
914%

Over the last year, the Total Equity growth was 914%.

Back to Top